Use of Recombinant Parainfluenza Viruses (PIVS) as Vectors To Protect Against Infection and Disease Caused By PIV and Other Human Pathogens Read more about Use of Recombinant Parainfluenza Viruses (PIVS) as Vectors To Protect Against Infection and Disease Caused By PIV and Other Human Pathogens Japan2001-544321Filed on 2000-12-08
Use of Recombinant Parainfluenza Viruses (PIVS) as Vectors To Protect Against Infection and Disease Caused By PIV and Other Human Pathogens Read more about Use of Recombinant Parainfluenza Viruses (PIVS) as Vectors To Protect Against Infection and Disease Caused By PIV and Other Human Pathogens Israel144831Filed on 2000-12-08
Use of Recombinant Parainfluenza Viruses (PIVS) as Vectors To Protect Against Infection and Disease Caused By PIV and Other Human Pathogens Read more about Use of Recombinant Parainfluenza Viruses (PIVS) as Vectors To Protect Against Infection and Disease Caused By PIV and Other Human Pathogens European Patent00984052.1Filed on 2000-12-08
Use of Recombinant Parainfluenza Viruses (PIVS) as Vectors To Protect Against Infection and Disease Caused By PIV and Other Human Pathogens Read more about Use of Recombinant Parainfluenza Viruses (PIVS) as Vectors To Protect Against Infection and Disease Caused By PIV and Other Human Pathogens China00805939.XFiled on 2000-12-08
Use of Recombinant Parainfluenza Viruses (PIVs) as Vectors to Protect against Infection and Disease Caused by PIV and Other Human Pathogens Read more about Use of Recombinant Parainfluenza Viruses (PIVs) as Vectors to Protect against Infection and Disease Caused by PIV and Other Human Pathogens Canada2362685Filed on 2000-12-08
Use of Recombinant Parainfluenza Viruses (PIV's) as Vectors To Protect Against Infection and Disease Caused By PIV and Other Human Pathogens Read more about Use of Recombinant Parainfluenza Viruses (PIV's) as Vectors To Protect Against Infection and Disease Caused By PIV and Other Human Pathogens BrazilPI0105530-5Filed on 2001-11-28
Use of Recombinant Parainfluenza Viruses (PIVs) as Vectors To Protect Against Infection and Disease Caused By PIV and Other Human Pathogens Read more about Use of Recombinant Parainfluenza Viruses (PIVs) as Vectors To Protect Against Infection and Disease Caused By PIV and Other Human Pathogens Australia20731/01Filed on 2000-12-08
Major Neutralization Site of Hepatitis E Virus and Use of this Neutralization Site in Methods of Vaccination and in Methods of Screeening for Neutralizing Antibodies to Hepatitis E Virus Read more about Major Neutralization Site of Hepatitis E Virus and Use of this Neutralization Site in Methods of Vaccination and in Methods of Screeening for Neutralizing Antibodies to Hepatitis E Virus European Patent00982311.3Filed on 2000-11-30
Mutated Anthrax Toxin Protective Antigen Proteins That Specifically Target Cells Containing High Amounts of Cell-Surface Metalloproteinases or Plasminogen Activator Receptors Read more about Mutated Anthrax Toxin Protective Antigen Proteins That Specifically Target Cells Containing High Amounts of Cell-Surface Metalloproteinases or Plasminogen Activator Receptors European Patent00989184.7Filed on 2000-09-22
Mutated Anthrax Toxin Protective Antigen Proteins That Specifically Target Cells Containing High Amounts of Cell-Surface Metalloproteinases or Plasminogen Activator Receptors Read more about Mutated Anthrax Toxin Protective Antigen Proteins That Specifically Target Cells Containing High Amounts of Cell-Surface Metalloproteinases or Plasminogen Activator Receptors Canada2385122Filed on 2000-09-22
